GT Medical Technologies
PrivateLast Round
Series E
Jun 9, 2026
Total Funding Raised
$262M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GT Medical Technologies is a medical device company that develops innovative therapeutic solutions, including the FDA-cleared GammaTile Therapy, to improve outcomes for patients with operable brain tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GT Medical Technologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
GT Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jun 9, 2026 | ||||
| Series D | Jul 15, 2025 | ||||
| Debt | Sep 12, 2024 | ||||
| Series C | Mar 23, 2023 | ||||
| Series B | Nov 23, 2020 | ||||
Series A | Feb 1, 2019 |
Key People
Founding team and executive leadership
GT Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Evidity Health Capital | Series E, Series D |
| Gilde Healthcare | Series E, Series D, Series C |
| Medical Technology Venture Partners | Series E, Series D, Series C, Series B, Series A, Seed |
| Warren Point Capital | Series D |
| Viking Global Investors | Series E |
| Horizon Technology Finance Corporation | Debt |
| BlueStone Venture Partners | Series A, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
$100M round led by Viking Global Investors
- Jul 15, 2025
$53M round completed.
GT Medical Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GT Medical Technologies's valuation, stock price, and market status.